Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:1285-1292
Published online before print September 11, 2006, doi: 10.1161/CIRCULATIONAHA.105.597013
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
114/12/1285    most recent
CIRCULATIONAHA.105.597013v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sommer, T.
Right arrow Articles by Schild, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sommer, T.
Right arrow Articles by Schild, H.
Related Collections
Right arrow Ablation/ICD/surgery
Right arrow Pacemaker
Right arrow CT and MRI
Right arrow Computerized tomography and Magnetic Resonance Imaging

(Circulation. 2006;114:1285-1292.)
© 2006 American Heart Association, Inc.


Imaging

Strategy for Safe Performance of Extrathoracic Magnetic Resonance Imaging at 1.5 Tesla in the Presence of Cardiac Pacemakers in Non–Pacemaker-Dependent Patients

A Prospective Study With 115 Examinations

Torsten Sommer, MD*; Claas P. Naehle, MD*; Alexander Yang, MD; Volkert Zeijlemaker, PhD; Matthias Hackenbroch, MD; Alexandra Schmiedel, MD; Carsten Meyer, MD; Katharina Strach, MD; Dirk Skowasch, MD; Christian Vahlhaus, MD; Harold Litt, MD, PhD; Hans Schild, MD

From the Departments of Radiology (T.S., C.P.N., M.H., A.S., C.M., K.S., H.S.) and Cardiology (A.Y., D.S.), University of Bonn, Bonn, Germany; Medtronic Bakken Research Center (V.Z.), Maastricht, Netherlands; Department of Cardiology and Angiology (C.V.), Hospital of the University of Muenster, Muenster, Germany; and Department of Radiology of the University of Pennsylvania School of Medicine (H.L.), Philadelphia, Pa.

Correspondence to Torsten Sommer, MD, Associate Professor of Radiology, Chief, Cardiovascular Imaging Section, University of Bonn, Department of Radiology, Sigmund Freud Straße 25, 53127 Bonn, Germany. E-mail t.sommer{at}uni-bonn.de

Received October 24, 2005; revision received June 19, 2006; accepted June 23, 2006.

Background— The purpose of the present study was to evaluate a strategy for safe performance of extrathoracic magnetic resonance imaging (MRI) in non–pacemaker-dependent patients with cardiac pacemakers.

Methods and Results— Inclusion criteria were presence of a cardiac pacemaker and urgent clinical need for an MRI examination. Pacemaker-dependent patients and those requiring examinations of the thoracic region were excluded. The study group consisted of 82 pacemaker patients who underwent a total of 115 MRI examinations at 1.5T. To minimize radiofrequency-related lead heating, the specific absorption rate was limited to 1.5 W/kg. All pacemakers were reprogrammed before MRI: If heart rate was <60 bpm, the asynchronous mode was programmed to avoid magnetic resonance (MR)–induced inhibition; if heart rate was >60 bpm, sense-only mode was used to avoid MR-induced competitive pacing and potential proarrhythmia. Patients were monitored with ECG and pulse oximetry. All pacemakers were interrogated immediately before and after the MRI examination and after 3 months, including measurement of pacing capture threshold (PCT) and serum troponin I levels. All MR examinations were completed safely. Inhibition of pacemaker output or induction of arrhythmias was not observed. PCT increased significantly from pre- to post-MRI (P=0.017). In 2 of 195 leads, an increase in PCT was only detected at follow-up. In 4 of 114 examinations, troponin increased from a normal baseline value to above normal after MRI, and in 1 case (troponin pre-MRI 0.02 ng/mL, post-MRI 0.16 ng/mL), this increase was associated with a significant increase in PCT.

Conclusions— Extrathoracic MRI of non–pacemaker-dependent patients can be performed with an acceptable risk-benefit ratio under controlled conditions and by taking both MR- and pacemaker-related precautions.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
CirculationHome page
S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, et al.
Feasibility of Real-Time Magnetic Resonance Imaging for Catheter Guidance in Electrophysiology Studies
Circulation, July 15, 2008; 118(3): 223 - 229.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Roguin, J. Schwitter, C. Vahlhaus, M. Lombardi, J. Brugada, P. Vardas, A. Auricchio, S. Priori, and T. Sommer
Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices
Europace, March 1, 2008; 10(3): 336 - 346.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. N. Levine, A. S. Gomes, A. E. Arai, D. A. Bluemke, S. D. Flamm, E. Kanal, W. J. Manning, E. T. Martin, J. M. Smith, N. Wilke, et al.
Safety of Magnetic Resonance Imaging in Patients With Cardiovascular Devices: An American Heart Association Scientific Statement From the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: Endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance
Circulation, December 11, 2007; 116(24): 2878 - 2891.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
C. M. Kramer, M. J. Budoff, Z. A. Fayad, V. A. Ferrari, C. Goldman, J. R. Lesser, E. T. Martin, S. Rajagopalan, J. P. Reilly, G. P. Rodgers, et al.
ACCF/AHA 2007 Clinical Competence Statement on vascular imaging with computed tomography and magnetic resonance
Vascular Medicine, November 1, 2007; 12(4): 359 - 378.
[PDF]


Home page
J Am Coll CardiolHome page
C. M. Kramer, M. J. Budoff, Z. A. Fayad, V. A. Ferrari, C. Goldman, J. R. Lesser, E. T. Martin, S. Rajagopalan, J. P. Reilly, G. P. Rodgers, et al.
ACCF/AHA 2007 Clinical Competence Statement on Vascular Imaging With Computed Tomography and Magnetic Resonance: A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training Developed in Collaboration With the Society of Atherosclerosis Imaging and Prevention, the Society for Cardiovascular Angiography and Interventions, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society for Vascular Medicine and Biology
J. Am. Coll. Cardiol., September 11, 2007; 50(11): 1097 - 1114.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Chalil, B. Stegemann, S. Muhyaldeen, K. Khadjooi, R. E.A. Smith, P. J. Jordan, and F. Leyva
Intraventricular Dyssynchrony Predicts Mortality and Morbidity After Cardiac Resynchronization Therapy: A Study Using Cardiovascular Magnetic Resonance Tissue Synchronization Imaging
J. Am. Coll. Cardiol., July 17, 2007; 50(3): 243 - 252.
[Abstract] [Full Text] [PDF]


Home page
JWatch Emergency Med.Home page
Can Patients with Implantable Cardiac Devices Safely Undergo MRI?
Journal Watch Emergency Medicine, October 20, 2006; 2006(1020): 3 - 3.
[Full Text]


Home page
CirculationHome page
O. P. Faris and M. Shein
Food and Drug Administration Perspective: Magnetic Resonance Imaging of Pacemaker and Implantable Cardioverter-Defibrillator Patients
Circulation, September 19, 2006; 114(12): 1232 - 1233.
[Full Text] [PDF]